Ongoing launch of CASGEVY® continues to gain momentum--2025 is poised to be a catalyst-rich year with key updates across several ...

Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business, largely due ...

Airborne delivered two mirror support structures for the FYST and SOLAT telescopes, assembling assembling 26,300 components.

We know the birth process is a team effort ... The reason a baby turns into the head down or vertex position is simply a matter of space. As the baby gets bigger, there is less room in the womb, and ...

It doesn’t mean this is the final position your baby will take for birth. A baby usually chooses a head-down ... You should expect your child to turn vertex (head down) from 30 weeks onward. If he’s ...

Vertex Pharmaceuticals Stock Up 3.1 % Shares of NASDAQ VRTX opened at $424.26 on Thursday. Vertex Pharmaceuticals Incorporated has a 52-week low of $377.85 and a 52-week high of $519.88. The ...

GHP Investment Advisors Inc. bought a new position in shares of Vertex Pharmaceuticals during the second quarter valued at $29,000. HBK Sorce Advisory LLC bought a new position in shares of Vertex ...

I last wrote here several months ago about the sodium channel (NaV1.8) inhibitor VX-548 (now known as suzetrigine), which is ...

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved the expanded use of TRIKAFTA ® (elexacaftor ...

On Sunday, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) announced multiple program updates, including: In December, the FDA approved Vertex's Alyftrek (vanzacaftor / tezacaftor ...

But businesses like Vertex don't just give up on a candidate when they hit a bump in the road, so investors shouldn't give up on it either. Alex Carchidi has no position in any of the stocks ...